Detalhe da pesquisa
1.
Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis.
Antimicrob Agents Chemother
; 66(11): e0122922, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36286542
2.
Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021.
Emerg Infect Dis
; 27(8): 2169-2173, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102098
3.
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany.
Emerg Infect Dis
; 27(8): 2174-2178, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102097
4.
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19.
JCI Insight
; 8(8)2023 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881474
5.
A survey among physicians in surgery and anesthesiology departments after the first surge of SARS-CoV-2 infections in Germany : Preparing for further challenges ahead.
Wien Klin Wochenschr
; 134(9-10): 361-370, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35061080
6.
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns.
Cell Host Microbe
; 30(9): 1231-1241.e6, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921836
7.
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers.
Cell Host Microbe
; 30(1): 69-82.e10, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973165
8.
Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults.
Lancet Infect Dis
; 22(4): 445-446, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240040